Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 89

Sort by

Sort Order Select

Journal Articles

A multi-timepoint immune profiling model for differentiating gvhd- and infection-associated diarrhea following allo-HSCT

Man Chen, Wei Zhao, Hui Wang

Blood (2025) 146 (Supplement 1): 4231.

https://doi.org/10.1182/blood-2025-4231

Published: 2025

Journal Articles

A cyno cross reactive CD3 VHH antibody enables engineering of a potent CD20-targeted t cell engager with enhanced safety

Blood (2025) 146 (Supplement 1): 3297.

https://doi.org/10.1182/blood-2025-3297

Published: 2025

Journal Articles

Transfusion dependence is associated with poor survival in MDS-h and MDS-LB, while transplantation improves outcomes

Wenjing Guo, Linlin Liu, Li Jia, Hui Wang, Aiming Pang, Erlie Jiang, Zhijian Xiao, Sizhou Feng

Blood (2025) 146 (Supplement 1): 7381.

https://doi.org/10.1182/blood-2025-7381

Published: 2025

Journal Articles

Detection of minimal residual disease in t-cell acute lymphoblastic leukemia by 16-color full-spectrum flow cytometry

Hui Wang, Meiwei Gong, Aixian Wang, Man Chen

Blood (2025) 146 (Supplement 1): 4333.

https://doi.org/10.1182/blood-2025-4333

Published: 2025

Journal Articles

primary efficacy and safety of first-line R-MTO regimen (rituximab, methotrexate, thiotepa, and orelabrutinib) followed by autologous hematopoietic stem cell transplantation in PCNSL

Haichen Wei, Xin Wang, Lijie Xing, Dan Liu, Hui Wang, Ping Li, Zengjun Li

Blood (2025) 146 (Supplement 1): 3687.

https://doi.org/10.1182/blood-2025-3687

Published: 2025

Journal Articles

Development and validation of a weighted cytokine scoring system for immune status Assessment Following CD19 CAR-T Therapy

Dongchu Wang, Fei Wang, Hui Wang

Blood (2025) 146 (Supplement 1): 5141.

https://doi.org/10.1182/blood-2025-5141

Published: 2025

Journal Articles

Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia

Peihua Lu, Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Meiwei Gong, Hui Wang, Jiaqi Chen, Hongxing Liu, Min Xiong, Ying Liu, Lin Wang

Blood (2025) 145 (10): 1022–1033.

https://doi.org/10.1182/blood.2024024861

Published: 2025

Includes: Supplemental data

Journal Articles

The Primary Results of R-MTO Regimen (Rituximab, Methotrexate, Thiotepa, and Orelabrutinib) As the First-Line Induction Therapy Followed By Autologous Stem Cell Transplantation in Newly Diagnosed Primary Central Nervous System Lymphoma

Haichen Wei, Lijie Xing, Dan Liu, Hui Wang, Ping Li, Zengjun Li

Blood (2024) 144 (Supplement 1): 1742.

https://doi.org/10.1182/blood-2024-204844

Published: 2024

Journal Articles

Real-World Effectiveness and Safety Analysis of Carfilzomib-Pomalidomide- Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Multicenter Retrospective Study from Eastern Shandong of China

Huishou Fan, Rongxia Wei, Xiangyan Feng, Xin Zhang, Tianlan Li, Lu Liu, Hui Wang, Lingjie Sun, Xue Shi, Hongguo Zhao, Zhao Li, Jingying Cui, Xianqi Feng, Junqing Xu, Junjie Ma, Lugui Qiu, Wei Wang

Blood (2024) 144 (Supplement 1): 7032.

https://doi.org/10.1182/blood-2024-207159

Published: 2024

Journal Articles

A Novel Full-Spectral Flow Cytometric Assay for Detection of Measurable Residual Disease in Patients with B-Lymphoblastic Leukemia

Ke Li, Man Chen, Meiwei Gong, Peihua Lu, Hui Wang

Blood (2024) 144 (Supplement 1): 5911.

https://doi.org/10.1182/blood-2024-203516

Published: 2024

Journal Articles

A China Survey on the Insights of Patients Living with Follicular Lymphoma: The Real-World Patient Journey Analysis

Yang He, Huilai Zhang, Bing Xu, Zengjun Li, Zheng Song, Qiuhui Jiang, Hui Wang, Weili Zhao

Blood (2024) 144 (Supplement 1): 7622.

https://doi.org/10.1182/blood-2024-206977

Published: 2024

Journal Articles

SNORD113-114 Cluster Maintains Hematopoietic Stem Cell Self-Renewal Via Orchestrating the Translation Machinery

Hui Wang, Zhaoru Zhang, Yingli Han, Weili Zhao, Penglei Jiang, Bing Liu, Jia Yu, Fang Wang, Pengxu Qian

Blood (2024) 144 (Supplement 1): 438.

https://doi.org/10.1182/blood-2024-199496

Published: 2024

Journal Articles

Clinical and Immunological Characteristics of Patients with CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Man Chen, Wei Zhao, Minjing Fu, Peihua Lu, Hui Wang

Blood (2024) 144 (Supplement 1): 4874.

https://doi.org/10.1182/blood-2024-199678

Published: 2024

Journal Articles

A Prospective Study of Rituximab/Bendamustine and Rituximab/DHAP +/- Zanubrutinib Induction Therapy with or without ASCT in Young Newly Diagnosed Mantle Cell Lymphoma

Hui Wang, Lijie Xing, Dan Liu, Haichen Wei, Ke Lu, Qiang He, Linna Xie, Ji Ma, Lugui Qiu, Zengjun Li

Blood (2024) 144 (Supplement 1): 6307.

https://doi.org/10.1182/blood-2024-206243

Published: 2024

Journal Articles

One High Efficient Detection Panel of Multiparamer Flow Cytometry for Non-Hematopoietic Tumors

Meiwei Gong, Hui Wang

Blood (2023) 142 (Supplement 1): 7166.

https://doi.org/10.1182/blood-2023-179873

Published: 2023

Journal Articles

Methotrexate in Combination with Orelabrutinib, Thiotepa, and Rituximab (R-MTO) Followed By Autologous Stem-Cell Transplant for Primary Central Nervous System Lymphoma Treatment

Lijie Xing, Haichen Wei, Dan Liu, Hui Wang, Ping Li, Linna Xie, Zengjun Li

Blood (2023) 142 (Supplement 1): 6228.

https://doi.org/10.1182/blood-2023-186219

Published: 2023

Journal Articles

Study on the Impact of G-CSF Mobilization on the Level of MDSCs in Donor Peripheral Blood and Its Correlation with Patient Prognosis

Man Chen, Rong Wang, Hui Wang

Blood (2023) 142 (Supplement 1): 7021.

https://doi.org/10.1182/blood-2023-180871

Published: 2023

Journal Articles

Relevant Studies on Cytokines Level and CAR-T Expansion Associated to CD7 CAR-T Therapy

Dongchu Wang, Hui Wang

Blood (2023) 142 (Supplement 1): 6857.

https://doi.org/10.1182/blood-2023-180843

Published: 2023

Journal Articles

Sgr-2921, a Potent CDC7 Inhibitor, Demonstrates Significant Anti-Leukemic Responses in Patient-Derived AML Models Representing Difficult-to-Treat Disease

Hooman Izadi, Hui Wang, Christian Atsriku, Zef Konst, Adam Levinson, Joseph Piccotti, Steven Pirie-Shepherd, Lin Tang, Dan Weiss, Karen Akinsanya, Hamish Wright, Kristian K Jensen

Blood (2023) 142 (Supplement 1): 2801.

https://doi.org/10.1182/blood-2023-181826

Published: 2023

Journal Articles

Final Results of the Phase 1/2 Study of Acalabrutinib Monotherapy in Treatment-Naive Chronic Lymphocytic Leukemia with >6 Years of Follow-up

John C. Byrd, Jennifer A. Woyach, Richard R. Furman, Peter Martin, Susan O'Brien, Jennifer R. Brown, Deborah M. Stephens, Jacqueline C. Barrientos, Piers EM Patten, Talha Munir, Krish Patel, Anna Butturini, Marianne de Borja, Min Hui Wang, Nitin Jain, William G. Wierda

Blood (2022) 140 (Supplement 1): 9865–9867.

https://doi.org/10.1182/blood-2022-159542

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A multi-timepoint immune profiling model for differentiating gvhd- and infection-associated diarrhea following allo-HSCT

A cyno cross reactive CD3 VHH antibody enables engineering of a potent CD20-targeted t cell engager with enhanced safety

Transfusion dependence is associated with poor survival in MDS-h and MDS-LB, while transplantation improves outcomes

Detection of minimal residual disease in t-cell acute lymphoblastic leukemia by 16-color full-spectrum flow cytometry

primary efficacy and safety of first-line R-MTO regimen (rituximab, methotrexate, thiotepa, and orelabrutinib) followed by autologous hematopoietic stem cell transplantation in PCNSL

Development and validation of a weighted cytokine scoring system for immune status Assessment Following CD19 CAR-T Therapy

Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia

The Primary Results of R-MTO Regimen (Rituximab, Methotrexate, Thiotepa, and Orelabrutinib) As the First-Line Induction Therapy Followed By Autologous Stem Cell Transplantation in Newly Diagnosed Primary Central Nervous System Lymphoma

Real-World Effectiveness and Safety Analysis of Carfilzomib-Pomalidomide- Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Multicenter Retrospective Study from Eastern Shandong of China

A Novel Full-Spectral Flow Cytometric Assay for Detection of Measurable Residual Disease in Patients with B-Lymphoblastic Leukemia

A China Survey on the Insights of Patients Living with Follicular Lymphoma: The Real-World Patient Journey Analysis

SNORD113-114 Cluster Maintains Hematopoietic Stem Cell Self-Renewal Via Orchestrating the Translation Machinery

Clinical and Immunological Characteristics of Patients with CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation

A Prospective Study of Rituximab/Bendamustine and Rituximab/DHAP +/- Zanubrutinib Induction Therapy with or without ASCT in Young Newly Diagnosed Mantle Cell Lymphoma

One High Efficient Detection Panel of Multiparamer Flow Cytometry for Non-Hematopoietic Tumors

Methotrexate in Combination with Orelabrutinib, Thiotepa, and Rituximab (R-MTO) Followed By Autologous Stem-Cell Transplant for Primary Central Nervous System Lymphoma Treatment

Study on the Impact of G-CSF Mobilization on the Level of MDSCs in Donor Peripheral Blood and Its Correlation with Patient Prognosis

Relevant Studies on Cytokines Level and CAR-T Expansion Associated to CD7 CAR-T Therapy

Sgr-2921, a Potent CDC7 Inhibitor, Demonstrates Significant Anti-Leukemic Responses in Patient-Derived AML Models Representing Difficult-to-Treat Disease

Final Results of the Phase 1/2 Study of Acalabrutinib Monotherapy in Treatment-Naive Chronic Lymphocytic Leukemia with >6 Years of Follow-up

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only